Detalles de la búsqueda
1.
Frequency of genetic alterations differs in advanced breast cancer between metastatic sites.
Genes Chromosomes Cancer
; 63(1): e23199, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672607
2.
Inflammation and vascular remodeling in COVID-19 hearts.
Angiogenesis
; 26(2): 233-248, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371548
3.
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance.
Mod Pathol
; 36(4): 100100, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788081
4.
Evaluation of the routine use of E-cadherin immunohistochemistry in the typing of breast carcinomas: results of a randomized diagnostic study.
Histopathology
; 83(5): 810-821, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37609779
5.
Comparison of Prenatal and Postmortem Diagnoses from 251 Fetal Autopsies: High Rate of Placenta Pathologies, Low Rate of Discrepancies.
Fetal Pediatr Pathol
; 42(4): 630-641, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129914
6.
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 625-635, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405088
7.
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Breast Cancer Res
; 24(1): 58, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056374
8.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
9.
Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
Br J Haematol
; 198(1): 114-130, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362549
10.
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
Mod Pathol
; 35(12): 1804-1811, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842479
11.
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
Blood
; 136(18): 2051-2064, 2020 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32726410
12.
Transcription factor AP-2beta in development, differentiation and tumorigenesis.
Int J Cancer
; 149(6): 1221-1227, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33720400
13.
Molecular Profiling of Vascular Remodeling in Chronic Pulmonary Disease.
Am J Pathol
; 190(7): 1382-1396, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32275906
14.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936950
15.
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression.
Eur J Haematol
; 106(4): 520-528, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460496
16.
[Relevant mutations in predictive breast cancer pathology]. / Prädiktive Mutationsdiagnostik bei Mammakarzinomen.
Pathologe
; 42(4): 399-404, 2021 Jul.
Artículo
en Alemán
| MEDLINE | ID: mdl-33822253
17.
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
Genes Chromosomes Cancer
; 59(8): 445-453, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32319699
18.
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Genes Chromosomes Cancer
; 59(3): 178-188, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31652375
19.
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
Breast Cancer Res
; 22(1): 47, 2020 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32408905
20.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Int J Cancer
; 146(1): 262-271, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31162838